Upperton Pharma Solutions has appointed Michael Mellor-Clark as its new Chief Commercial Officer (CCO), marking a strategic addition to the leadership team during a period of expansion into sterile manufacturing and commercial production in the EU and US. The appointment follows
Upperton Pharma Solutions has been named a Champion Winner in the Small Molecule Dosage Form – International category at the 2025 CDMO Leadership Awards. The awards, presented by Outsourced Pharma and Life Science Connect, recognise contract development and manufacturing organisations (CDMOs)
Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO), has announced the completion of a new sterile manufacturing facility in Nottingham, UK. This addition complements the company’s existing 50,000 sq. ft. Trent Gateway site and is specifically designed
Upperton Pharma Solutions has announced the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sq ft development and GMP manufacturing facility in Nottingham, UK. This inspection, conducted by the UK Government’s
Upperton Pharma Solutions Contract Manufacturing & Development (CDMO) Profile Upperton Pharma Solutions is a UK-based leading contract development and manufacturing organisation (CDMO) specialising in formulation development, clinical trial manufacturing and manufacturing services for a wide range of dosage forms, including
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
